Today: 21 May 2026
SanDisk (SNDK) stock slips as fresh Wall Street target hikes collide with profit-taking
26 January 2026
1 min read

SanDisk (SNDK) stock slips as fresh Wall Street target hikes collide with profit-taking

New York, January 26, 2026, 10:03 EST — Regular session

  • SanDisk shares fell about 1.5% in morning trade, lagging gains in some storage peers.
  • Morgan Stanley and Cantor Fitzgerald lifted price targets on the stock in Monday research notes.
  • Investors now turn to SanDisk’s Jan. 29 results for clues on flash-memory pricing and guidance.

SanDisk shares were down about 1.5% at $466.69 on Monday morning, after swinging between $454.79 and $478.69 earlier in the session.

The dip lands after a sharp run that has left the stock trading on expectations, not patience. With earnings due this week, even small shifts in outlook can move the price fast.

Two bullish calls hit the tape before the bell. Morgan Stanley raised its price target on SanDisk to $483 from $273 and kept an “Overweight” rating, while Cantor Fitzgerald lifted its target to $550 from $300 and also reiterated “Overweight,” MT Newswires reported. Asktraders said the Morgan Stanley note leaned on stronger assumptions for NAND pricing, the flash-memory component that sits at the core of SanDisk’s products. MarketScreener

SanDisk’s move ran against parts of its neighborhood. Western Digital rose about 5.3% and Seagate gained roughly 5.5%, while Micron slipped about 2.2%.

The company is slated to report fiscal second-quarter results on Thursday, Jan. 29, and will host an earnings conference call at 1:30 p.m. Pacific time, it said.

SanDisk began trading as a stand-alone company in February 2025 after completing its separation from Western Digital, the company said at the time.

What matters now is the setup: investors want to hear whether pricing for NAND flash (a type of memory chip used in solid-state storage) is holding up, and whether demand tied to data centers and enterprise solid-state drives is still strong enough to justify the stock’s premium.

There is also a simpler force at work: crowding. A stock that has moved this much can fall on nothing more than traders taking money off the table.

But the risk runs both ways. If management’s forecast disappoints, or if comments hint at easing supply tightness and softer pricing, the stock could see another hard downdraft.

The next catalyst is Thursday’s results and the guidance that follows, with investors parsing every line on demand, pricing and the company’s view of the next quarter.

Stock Market Today

  • Bitmine Immersion Technologies Uplists to NYSE, Holds 5M+ ETH as Ethereum Proxy, Launches MAVAN Staking
    May 21, 2026, 12:11 AM EDT. Bitmine Immersion Technologies (NYSE:BMNR) has become a major Ethereum proxy by accumulating over 5 million ETH, representing more than 4.3% of Ethereum's total supply. The company uplisted to the NYSE and introduced MAVAN, an institutional-grade Ethereum staking platform, shifting its focus beyond mining to include staking services. BMNR stock closed at $19.39, trading below analyst targets and experiencing recent price declines despite longer-term gains. Investors should watch Ethereum price trends, staking yields, and institutional adoption of MAVAN, while noting BMNR remains loss-making and has diluted shareholders.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
The Impact of ChatGPT on Mental Health and Wellbeing: AI Therapy Boom Faces a Safety Reckoning
Previous Story

The Impact of ChatGPT on Mental Health and Wellbeing: AI Therapy Boom Faces a Safety Reckoning

Amazon stock price slips as AWS lands Nationwide deal and earnings loom
Next Story

Amazon stock price slips as AWS lands Nationwide deal and earnings loom

Go toTop